Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

57.600
-2.500-4.16%
Volume:4.12M
Turnover:232.69M
Market Cap:33.58B
PE:-12.86
High:57.700
Open:57.000
Low:55.700
Close:60.100
52wk High:80.900
52wk Low:29.980
Shares:583.00M
HK Float Shares:583.00M
Volume Ratio:0.34
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:7.82
PE(LYR):-12.86
PS:31.68

Loading ...

Movement Alert|Insilico Medicine Rises 5.81% in Regular Trading, Strategic Collaboration with Takeda Worth Up to $600 Million

Market Focus
·
Jul 02

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Insilico Medicine and Takeda Sign AI-Driven Drug Discovery Deal Worth up to USD600 million

Bulletin Express
·
Jul 02

Insilico Medicine Cayman Announces Drug Discovery Collaboration with Takeda Worth up to $600 Million

Reuters
·
Jul 02

Insilico Medicine Cayman Topco - Takeda Granted Exclusive Worldwide Rights to Develop and Commercialize Collaboration Therapeutics

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Deal Value up to Usd600 Mln Including USD60 Mln in Upfront and Near-term Payments

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Voluntary Announcement Insilico Medicine and Takeda Achieved Strategic Ai-powered Drug Discovery Collaboration Worth up to Usd600 Mln

THOMSON REUTERS
·
Jul 02

Takeda Will be Granted Exclusive Worldwide Rights Under Insilico Deal to Develop, Manufacture and Commercialize New Drugs - WSJ

THOMSON REUTERS
·
Jul 02

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Dow Jones
·
Jul 02

Insilico Leadership Voluntarily Extends Share Lock-Up Period

Stock News
·
Jun 30

Movement Alert|Insilico Medicine Falls 11.12% in Regular Trading, Massive Lock-up Share Expiry Triggers Concentrated Selling Pressure

Market Focus
·
Jun 30

Movement Alert|Insilico Medicine Falls 5.7% in Regular Trading, Selling Pressure Intensifies Ahead of Massive Lock-Up Expiry

Market Focus
·
Jun 29

Movement Alert|Insilico Medicine Falls 5.76% in Regular Trading, Profit-Taking Intensifies Ahead of Massive Lock-Up Expiry

Market Focus
·
Jun 26

Movement Alert|Insilico Medicine Rises 5.64% in Regular Trading, SK Biopharmaceuticals $2.5 Billion AI-Driven Collaboration Continues to Fuel Rally

Market Focus
·
Jun 25

Movement Alert|Insilico Medicine Rises 6.34% in Regular Trading, SK Biopharmaceuticals USD 2.5 Billion AI-Driven Collaboration Continues to Fuel Rally

Market Focus
·
Jun 24

Movement Alert|Insilico Medicine Rises 5.95% in Regular Trading, SK Biopharmaceuticals USD 2.5 Billion AI-Driven Collaboration Continues to Boost Sentiment

Market Focus
·
Jun 23

Hong Kong Stocks Decline on Renewed U.S.-China Friction; Shenzhen HQVT Technology Shines on Debut

MT Newswires Live
·
Jun 22

Shaers of Insilico Medicine Jump More Than 15% on SK Biopharmaceuticals Tie-up

THOMSON REUTERS
·
Jun 22

Insilico Medicine seals AI-driven neuroimmune R&D deal worth up to USD2.50 billion with SK Biopharmaceuticals

Bulletin Express
·
Jun 22

Insilico Partners with SK Biopharmaceuticals in AI-Powered Neuroscience Drug Discovery Deal Valued Up to $2.5 Billion

Stock News
·
Jun 22